Position in ICLR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$281,062
-$220,771 QoQ
Shares Held
1,618
-41.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#277
of 422 holders
Holding Since
Mar 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ICLR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Quantinno Capital Management LP holds $891,072,827 across 29 Diagnostics & Research names. ICLR ranks #28 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ILMN |
Illumina, Inc.
|
670,767 | $117,940,961 | |
| 2 | A |
Agilent Technologies, Inc.
|
870,573 | $115,638,211 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
201,049 | $100,797,926 | |
| 4 | DHR |
Danaher Corp /De/
|
456,740 | $86,999,835 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
164,289 | $86,488,301 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
357,824 | $69,138,753 | |
| 7 | DGX |
Quest Diagnostics Inc
|
252,924 | $53,607,241 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
216,150 | $49,020,658 |
All Filings in ICLR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $281,062 | 1,618 | Shares | Sole | 2026-08-13 | |
| 2025-12-31 | $501,833 | 2,754 | Shares | Sole | 2026-02-17 | |
| 2024-09-30 | $376,088 | 1,309 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $336,980 | 1,075 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $269,767 | 803 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $229,286 | 810 | Shares | Sole | 2024-02-14 | |
| 2020-03-31 | $243,440 | 1,790 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||